I'm wondering if some of the "old timers" can englighten me with respect to these American Heart Association Sessions?

I'm seeing that Resverlogix has presented there before, back in 2008 and 2010.  

https://www.fiercebiotech.com/biotech/resverlogix-presents-assert-human-clinical-trial-data-at-american-heart-association-late

http://www.newswire.ca/news-releases/resverlogix-advances-to-second-arm-of-phase-1b2a-clinical-trial-536758511.html

That's long before I establish a position here, but I'm sure there are others who were invested in RVX when those presentations took place.  Question....Have there been other presentations to the AHA, or just these two?

In looking at the chart it looks like those AHA presentations coincided with a much higher PPS for RVX, although obviously the share structure was much different back then.  Does anyone recall what the market capitalization was around those times?